as on October 30, 2025 at 7:39 pm IST
Day's Low
Day's High
1.64%
Downside
1.40%
Upside
52 Week's Low
52 Week's High
58.41%
Downside
91.12%
Upside
Check Adverum Biotechnologies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$93.7M
EPS (TTM)
-5.31
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-172.2M
Revenue (TTM)
1.0M
Profit Margin
0.00%
Return On Equity TTM
-229.34%
Compare market cap, revenue, PE, and other key metrics of Adverum Biotechnologies Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $93.7M | -96.12% | NA | 0.00% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% |
The Adverum Biotechnologies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adverum Biotechnologies Inc investment value today
Current value as on today
₹59,981
Returns
Returns from Adverum Biotechnologies Inc Stock
Dollar Returns*
₹5,667 (+5.67%)
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Adverum Biotechnologies Inc. Average target price of $11.2
Get share price movements and forecasts by analysts on Adverum Biotechnologies Inc.
What analysts predicted
61.79%UPSIDE
Target Price
$11.2
Current Price
$4.28
Analyzed by
13 Analysts
Target
$11.20
Adverum Biotechnologies Inc target price $11.2, a slight upside of 61.79% compared to current price of $4.28. According to 13 analysts rating.
Search interest for Adverum Biotechnologies Inc Stock has increased by 222% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:222% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 24 October
Fri, 11:06 PM
-Eli Lilly enters definitive agreement to acquire Adverum Biotechnologies, launching a tender offer for all outstanding shares.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, ADVM stock has moved up by 77.0%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 135.5% return, outperforming this stock by 188.8%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.1% return, outperforming this stock by 117.4%
| Organisation | Adverum Biotechnologies Inc |
| Headquarters | 100 Cardinal Way, Redwood City, CA, United States, 94063 |
| Industry | Health Technology |
| CEO | Dr. Laurent Fischer M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. R. Andrew Ramelmeier Ph.D. | Chief Technology Officer |
Dr. Laurent Fischer M.D. | President, CEO & Director |
Ms. Linda M. Rubinstein M.A. | CFO, Principal Financial Officer & Principal Accounting Officer |
Dr. Setareh Seyedkazemi Pharm.D. | Chief Development Officer |
Dr. Rabia Gurses Ozden M.D. | Chief Medical Officer |
Ms. Carla Fiankan | Senior Vice President of Regulatory Affairs |
Mr. Kishor Peter Soparkar J.D. | Chief Operating Officer |
Dr. Romuald Corbau Ph.D. | Chief Scientific Officer |
Ms. Aneta Ferguson | General Counsel |
Ms. Dena House | Chief People Officer |
Adverum Biotechnologies Inc share price today is $4.28 as on . Adverum Biotechnologies Inc share today touched a day high of $4.34 and a low of $4.21.
Adverum Biotechnologies Inc share touched a 52 week high of $8.18 on and a 52 week low of $1.78 on . Adverum Biotechnologies Inc stock price today i.e. is trending at $4.28,which is 47.68% down from its 52 week high and 140.45% up from its 52 week low.
Adverum Biotechnologies Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Adverum Biotechnologies Inc (ADVM) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Adverum Biotechnologies Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Adverum Biotechnologies Inc share’s latest price of $4.28 as on October 30, 2025 at 7:39 pm IST, you will get 2.3364 shares of Adverum Biotechnologies Inc. Learn more about
fractional shares .
Adverum Biotechnologies Inc stock has given -96.12% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?